Second, our bioinformatic analysis of cancer patients indicates that DNASE1L3 could be evaluated as a predictive biomarker for risk and prognosis of various human cancers, and this is also supported by 2 recent studies (33, 36). The gene discussed is DNASE1L3; the disease is cancer.